U.S. MARKETS FOR POINT-OF-CARE DIAGNOSTICS

232 Pages | 58 Exhibits | 2003 Analysis | Forecasts Through 2006

OVERVIEW:
Point-of-care diagnostic technology includes portable, instrument-based diagnostic devices used in near-patient hospital and alternate care settings. In 2001, U.S. sales of point-of-care diagnostic devices totaled approximately $2.8 billion and are expected to increase over the forecast period covered by this report.

This report by Medtech Insight analyzes major market segments for point-of-care products used in the hospital setting and at alternate care sites. These market segments include infectious disease diagnosis, diabetes monitoring, cardiovascular disease diagnosis, and respiratory disease diagnosis. Major topics include: blood gas analysis, blood glucose testing, cardiac markers, cholesterol testing, coagulation monitoring, diabetes management, pulse oximetry, and spirometry.

TABLE OF CONTENTS:

EXECUTIVE SUMMARY

i. Point-of-Care Diagnostic Products for Infectious Diseases

ii. Point-of-Care Products for Diabetes Monitoring

iii. Point-of-Care Diagnostic Products for Cardiovascular Diseases

iv. Point-of-Care Diagnostic Products for Respiratory Disorders

v. Total Point-of-Care Diagnostic Products Market

1. POINT-OF-CARE DIAGNOSTIC PRODUCTS FOR INFECTIOUS DISEASES

1.1 Selected Infectious Diseases Targeted by Point-of-Care Diagnostics

1.1.1 Acquired Immunodeficiency Syndrome/Human Immunodeficiency Virus

1.1.2 Chlamydia

1.1.3 Helicobacter Pylori

1.1.4 Hepatitis

1.1.5 Influenza

1.1.6 Mononucleosis

1.1.7 Respiratory Syncytial Virus

1.1.8 Streptococcus

1.2 Point-of-Care Diagnosis of Infectious Diseases

1.2.1 Technologies and Products

1.2.2 Market Analysis

1.2.2.1 Helicobacter Pylori Diagnostic Kits

1.2.2.1.1 Supplier Shares

1.2.2.2 Influenza Diagnostic Kits

1.2.2.2.1 Supplier Shares

1.2.2.3 Streptococcus Diagnostic Kits

1.2.2.3.1 Supplier Shares

1.2.2.4 Other Diagnostic Kits

1.2.2.4.1 Supplier Shares

2. POINT-OF-CARE PRODUCTS FOR DIABETES MONITORING

2.1 Diabetes Etiology and Epidemiology

2.1.1 Type 1 Diabetes

2.1.2 Type 2 Diabetes

2.1.3 Gestational Diabetes

2.1.4 Impaired Fasting Glucose and Impaired Glucose Tolerance

2.1.5 Incidence, Prevalence, and Cost

2.2 Diabetes Management

2.2.1 Blood Glucose Testing

2.2.1.1 Personal Blood Glucose Meters

2.2.1.1.1 Lancing Devices

2.2.1.2 Noninvasive Blood Glucose Monitoring

2.2.1.2.1 Current and Emerging Technology

2.2.1.3 In Vivo Blood Glucose Monitoring

2.2.1.4 Glycated Hemoglobin Testing

2.2.1.5 Fasting Plasma Glucose Testing

2.2.1.6 Glucose Tolerance Testing

2.2.1.7 Urine Glucose Measurement

2.2.1.8 Urine Ketone Testing

2.2.1.9 Emerging Diagnostic Tests

2.3 Market Analysis

2.3.1 Blood Glucose Testing Products

2.3.1.1 Supplier Shares

2.3.2 Lancing Devices

2.3.2.1 Supplier Shares

2.3.3 Ancillary Blood and Urine Testing Products

2.3.3.1 Supplier Shares

3. POINT-OF-CARE DIAGNOSTIC PRODUCTS FOR CARDIOVASCULAR DISEASE

3.1 Cardiovascular Diseases Targeted by Point-of-Care Diagnostic Products

3.1.1 Acute Myocardial Infarction

3.1.2 Angina Pectoris

3.1.3 Atherosclerosis

3.1.4 Atrial Fibrillation

3.1.5 Cardiac Valve Disorders

3.1.6 Congestive Heart Failure

3.1.7 Coronary Artery Disease

3.1.8 Deep Vein Thrombosis and Pulmonary Embolism

3.1.9 Hypercholesterolemia

3.1.10 Ischemic Stroke

3.2 Technologies and Products

3.2.1 Cholesterol Testing

3.2.1.1 Point-of-Care Cholesterol Testing Systems

3.2.2Cardiac Markers

3.2.2.1 Acute Myocardial Infarction Markers

3.2.2.1.1 Creatine Kinase MB

3.2.2.1.2 Myoglobin

3.2.2.1.3 Cardiac Troponin

3.2.2.2 Biochemical Markers for Congestive Heart Failure

3.2.2.2.1 B-Type Natriuretic Peptide Testing

3.2.2.3 Point-of-Care Cardiac Marker Products

3.2.3 Coagulation Monitoring

3.2.3.1 Types

3.2.3.1.1 Activated Partial Thromboplastin Time Test

3.2.3.1.2 Activated Clotting Time Test

3.2.3.1.3 Bleeding Time Test

3.2.3.1.4 Prothrombin Time Test

3.2.3.1.5 Thrombin Clotting Time Test

3.2.3.1.6 Diagnostic Tests

3.2.3.2 Technologies and Products

3.3 Market Analysis

3.3.1 Cholesterol Testing Systems

3.3.1.1 Supplier Shares

3.3.2 Cardiac Markers

3.3.2.1 Supplier Shares

3.3.3 Coagulation Monitoring Systems

3.3.3.1 Supplier Shares

4. POINT-OF-CARE DIAGNOSTIC PRODUCTS FOR RESPIRATORY DISORDERS

4.1 Selected Respiratory Disorders

4.1.1 Adult Respiratory Distress Syndrome

4.1.2 Apnea

4.1.2.1 Central Sleep Apnea

4.1.2.2 Obstructive Sleep Apnea

4.1.3 Asthma

4.1.4 Chronic Bronchitis

4.1.5 Cystic Fibrosis

4.1.6 Infectious Respiratory Diseases

4.1.6.1 Pneumonia

4.1.6.2 Tuberculosis

4.1.7 Pleural Diseases

4.1.7.1 Empyema

4.1.7.2 Pleural Effusion

4.1.7.3 Pneumothorax

4.1.8 Pulmonary Emphysema

4.1.9 Respiratory Failure

4.1.10 Restrictive Pulmonary Diseases

4.2 Point-of-Care Respiratory Diagnostic Technologies and Products

4.2.1 Arterial Blood Gas Analysis

4.2.1.1 Technology and Products

4.2.2 Oximetry

4.2.2.1 Technology and Products

4.2.3 Pulmonary Function Assessment Systems

4.2.3.1 Spirometry

4.2.3.1.1 Technology and Products

4.3 Market Analysis

4.3.1 Arterial Blood Gas Analysis Products

4.3.1.1 Supplier Shares

4.3.2 Pulse Oximetry Products

4.3.2.1 Supplier Shares

4.3.3 Spirometry Products

4.3.3.1 Share by Supplier

5. COMPANY PROFILES

5.1 Abbott Laboratories

5.2 Bayer Diagnostics, Inc./Bayer AG

5.3 Beckman Coulter, Inc.

5.4 Becton Dickinson, Inc.

5.5 Biosite, Inc.

5.6 Cholestech Corporation

5.7 Cygnus, Inc.

5.8 Datex-Ohmeda, Inc./Instrumentarium Corporation

5.9 International Technidyne Corporation/Thoratec, Inc.

5.10 i-STAT Corporation

5.11 LifeScan, Inc./Johnson & Johnson

5.12 Mallinckrodt, Inc./Tyco International LTD

5.13 Medtronic, Inc.

5.14 Philips Medical Systems, Inc./Royal Philips Electronics NV

5.15 Quidel Corporation

5.16 Roche Diagnostics, Inc./F. Hoffmann-La-Roche LTD

5.17 Thermo BioStar, Inc./Thermo Electron Corporation

5.18 Trinity Biotech, Inc.

5.19 Welch Allyn, Inc.

APPENDIX: COMPANY PROFILES

LIST OF EXHIBITS

Exhibit ES-1: 2001, Selected Infectious Conditions and Diseases, Incidence
and Prevalence

Exhibit ES-2: Point-of-Care Diagnostic Products for Infectious Diseases, Market Forecast, 2001-2006

Exhibit ES-3: Diabetes Mellitus, Prevalence Forecast, by Type, 2001-2006

Exhibit ES-4: Point-of-Care Products for Diabetes Monitoring, Market Forecast, 2001-2006

Exhibit ES-5: Selected Cardiovascular Diseases and Disorders Targeted by Point-of-Care Diagnostics, Incidence and Prevalence Forecast, 2001 and 2006

Exhibit ES-6: Point-of-Care Diagnostic Products for Cardiovascular Disease, Market Forecast, 2001-2006

Exhibit ES-7: Selected Respiratory Disorders Targeted by Point-of-Care Diagnostics, Prevalence Forecast, 2001 and 2006

Exhibit ES-8: Point-of-Care Diagnostic Products for Respiratory Diseases, Market Forecast, 2001-2006

Exhibit ES-9: Point-of-Care Diagnostic Products, Market Forecast, 2001-2006

Exhibit 1-1: 2001, Selected Infectious Conditions and Diseases, Incidence and Prevalence

Exhibit 1-2: 2003, Selected Point-of-Care Diagnostic Products for Infectious Diseases

Exhibit 1-3: Point-of-Care Diagnostic Products for Infectious Diseases, Market Forecast, 2001-2006

Exhibit 1-4: Helicobacter Pylori Diagnostic Kits, Market Forecast, 2001-2006

Exhibit 1-5: 2001, Helicobacter Pylori Diagnostic Kits Market, Share by Supplier

Exhibit 1-6: Influenza Diagnostic Kits, Market Forecast, 2001-2006

Exhibit 1-7: 2001, Influenza Diagnostic Kits Market, Share by Supplier

Exhibit 1-8: Group A Streptococcus Diagnostic Kits, Market Forecast, 2001-2006

Exhibit 1-9: 2001, Group A Streptococcus Diagnostic Kits Market, Share by Supplier

Exhibit 1-10: Other Infectious Disease Diagnostic Kits, Market Forecast, 2001-2006

Exhibit 1-11: 2001, Other Infectious Disease Diagnostic Kits Market, Share by Supplier

Exhibit 2-1: Diabetes Mellitus, Prevalence Forecast, by Type, 2001-2006

Exhibit 2-2: Blood Glucose Self-Testing, Procedure Volumes Forecast, 2001-2006

Exhibit 2-3: 2003, Selected Blood Glucose Monitoring Systems

Exhibit 2-4: 2003, Selected Lancing Devices

Exhibit 2-5: 2003, Selected Current and Emerging Noninvasive Blood Glucose Monitoring Systems

Exhibit 2-6: Relationship Between Glycated Hemoglobin and Blood Glucose Levels

Exhibit 2-7: 2003, Selected Home-Based Glycated Hemoglobin Testing Products

Exhibit 2-8: 2003, Selected Urine Glucose and Ketone Home-Testing Products

Exhibit 2-9: Point-of-Care Products for Diabetes Monitoring, Market Forecast, 2001-2006

Exhibit 2-10: Blood Glucose Testing Products, Market Forecast, 2001-2006

Exhibit 2-11: 2001, Blood Glucose Testing Products Market, Share by Supplier

Exhibit 2-12: Lancing Devices, Market Forecast, 2001-2006

Exhibit 2-13: 2001, Lancing Devices Market, Share by Supplier

Exhibit 2-14: Ancillary Blood and Urine Testing Products, Market Forecast, 2001-2006

Exhibit 2-15: 2001, Glycated Hemoglobin Testing Kits Market, Share by Supplier

Exhibit 2-16: 2001, Urine Reagent Strips Market, Share by Supplier

Exhibit 3-1: Selected Cardiovascular Diseases and Disorders Targeted by Point-of-Care Diagnostics, Incidence and Prevalence Forecast, 2001 and 2006

Exhibit 3-2: 2003, Selected Point-of-Care Cholesterol Testing Products

Exhibit 3-3: 2003, Selected Point-of-Care Cardiac Marker Products

Exhibit 3-4: 2003, Selected Point-of-Care Coagulation Monitoring Systems

Exhibit 3-5: Point-of-Care Diagnostic Products for Cardiovascular Diseases, Market Forecast, 2001-2006

Exhibit 3-6: Point-of-Care Cholesterol Testing Systems, Market Forecast, 2001-2006

Exhibit 3-7: 2001, Point-of-Care Cholesterol Testing Systems Market, Share by Supplier

Exhibit 3-8: Point-of-Care Cardiac Marker Systems, Market Forecast, 2001-2006

Exhibit 3-9: 2001, Point-of-Care Cardiac Marker Systems Market, Share by Supplier

Exhibit 3-10: Point-of-Care Coagulation Testing Systems, Market Forecast, 2001-2006

Exhibit 3-11: 2001, Point-of-Care Coagulation Testing Systems Market, Share by Supplier

Exhibit 4-1: Selected Respiratory Disorders Targeted by Point-of-Care Diagnostics, Prevalence Forecast, 2001 and 2006

Exhibit 4-2: 2003, Selected Point-of-Care Arterial Blood Gas Analyzers

Exhibit 4-3: 2003, Selected Point-of-Care Pulse Oximetry Products

Exhibit 4-4: 2003, Selected Point-of-Care Spirometry Products

Exhibit 4-5: Point-of-Care Diagnostic Products for Respiratory Diseases, Market Forecast, 2001-2006

Exhibit 4-6: Point-of-Care Arterial Blood Gas Analysis Products, Market Forecast, 2001-2006

Exhibit 4-7: 2001, Point-of-Care Arterial Blood Gas Analysis Products Market, Share by Supplier

Exhibit 4-8: Point-of-Care Pulse Oximetry Products, Market Forecast, 2001-2006

Exhibit 4-9: 2001, Point-of-Care Pulse Oximetry Products Market, Share by Supplier

Exhibit 4-10: Point-of-Care Spirometry Products, Market Forecast, 2001-2006

Exhibit 4-11: 2001, Point-of-Care Spirometry Products Market, Share by Supplier



COMPANIES COVERED:

  1. Abbott Laboratories
  2. Bayer Diagnostics, Inc./Bayer AG
  3. Beckman Coulter, Inc.
  4. Becton Dickinson, Inc.
  5. Biosite, Inc.
  6. Cholestech Corporation
  7. Cygnus, Inc.
  8. Datex-Ohmeda, Inc./Instrumentarium Corporation
  9. International Technidyne Corporation/Thoratec, Inc.
  10. i-STAT Corporation
  11. LifeScan, Inc./Johnson & Johnson
  12. Mallinckrodt, Inc./Tyco International LTD
  13. Medtronic, Inc.
  14. Philips Medical Systems, Inc./Royal Philips Electronics NV
  15. Quidel Corporation
  16. Roche Diagnostics, Inc./F. Hoffmann-La-Roche LTD
  17. Thermo BioStar, Inc./Thermo Electron Corporation
  18. Trinity Biotech, Inc.
  19. Welch Allyn, Inc
Contact Us

Need help finding medtech research? Let us help you!